The gp130 signaling pathway plays a crucial role in regulating cardiac myocyte growth, myocardial remodeling, and cytoprotection in cardiovascular diseases.
No takes yet. Share an insight, caveat, or question.
Gp130 signaling remains preclinical for cardiac remodeling; leaves open targeted interventions pending clinical trials.
Yamauchi‐Takihara et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: